Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea is the most commonly reported side effect of Wegovy, but most people find it manageable and short-lived — it tends to peak in the first week or two after a new dose and then ease off as your body adjusts. Dealing with nausea from Wegovy doesn't usually mean stopping treatment; it often means changing a few small habits around how and when you eat. These are prescription-only medicines requiring clinical assessment, and a prescriber can help you weigh the side-effect picture against the benefits before you start.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common thing people get wrong is treating nausea as a signal to stop. It isn't. Wegovy slows how quickly food leaves your stomach (that's a core part of how it works) and nausea is largely a consequence of that, particularly while your digestive system is getting used to the medicine. It is unpleasant, sometimes genuinely rough. But in clinical trials, nausea was most intense in the first few weeks of each dose level and then settled for the vast majority of participants. Stopping because of early nausea means missing out on a medicine that may have become comfortable within a fortnight.
The pattern of nausea with Wegovy follows a predictable arc: higher after a dose increase, lower once that dose becomes familiar. That arc repeats at each step of the titration schedule. Knowing it's coming, and knowing it passes, changes how you experience it. Our prescribers at nume talk through this timeline during the consultation because it's exactly the kind of context that helps people stay the course.
There is one important caveat. Ordinary Wegovy nausea is mild to moderate, linked to eating, and gets better. Pain that is severe, doesn't pass, and radiates into your back is a different thing, and that's covered in more detail below.
Small meals help more than people expect. The slowed gastric emptying that causes nausea gets worse when the stomach is suddenly asked to process a large volume of food. Eating until you are comfortably full rather than stuffed, choosing lower-fat and lower-spice options, and avoiding lying down immediately after eating all reduce the severity. Fizzy drinks and alcohol tend to make it worse.
Timing matters too. Many people find nausea peaks a day or two after their weekly injection. Tracking this against your injection day can help you plan, some people prefer injecting at the weekend so any rough patch lands when they're not at work. Staying hydrated is more important than it sounds; practical strategies for easing Wegovy-related nausea usually start with fluid intake, because dehydration compounds GI discomfort and risks kidney strain if vomiting is also present.
One routine detail that comes up often: keeping the pen in the fridge door next to familiar, everyday things tends to prompt people to inject consistently, and consistency with injection timing reduces the unpredictability that makes nausea harder to manage. There is no magic fix, but regularity helps. The NHS semaglutide guidance also notes that ginger-containing foods and drinks may ease mild nausea for some people, and smaller, more frequent meals are consistently better than three large ones.
For most people, nausea from Wegovy is worst in the first one to two weeks after a new dose and then fades. Once maintenance dose is reached and the titration stops, many people report that their digestive tolerance has improved considerably from where it was in week one. How long nausea lasts on Wegovy varies between individuals, but persistent severe nausea that doesn't follow this settling pattern (or nausea accompanied by signs of dehydration such as dizziness, very dark urine, or significantly reduced urination) warrants contacting your prescribing team rather than waiting it out.
If you are a nume patient and something feels wrong, our aftercare team is available seven days a week. General information about the full range of Wegovy side effects may also help you distinguish normal adjustment from something that needs attention.
Nausea that is severe, unremitting and accompanied by sharp pain spreading from the stomach to the back needs urgent medical assessment, not a tip about ginger tea. The MHRA's January 2026 Drug Safety Update for GLP-1 receptor agonists identified acute pancreatitis as a known, infrequent but serious risk. It is rare; it is also serious enough that the warning is clear: if that particular pain pattern develops, seek help the same day.
Other symptoms that should prompt you to contact a doctor rather than manage at home include signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, more detail on Wegovy allergy symptoms), persistent vomiting that stops you keeping fluids down, and significant dizziness or confusion. These are not typical nausea. They are different in character and require clinical assessment.
For anything less urgent (nausea that is manageable but dragging on, questions about coffee or other dietary triggers, whether a particular pattern of symptoms is normal) some interactions with everyday habits like caffeine are worth knowing about. And if you haven't started treatment yet and want to talk through the side-effect picture with a prescriber before committing, our consultation is free and covers this in full.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.